Section Arrow
VOR.NASDAQ
- Vor Biopharma Inc
Quotes are at least 15-min delayed:2026/01/05 04:53 EST
Pre Market
Last
 11.99
+0.35 (+3.01%)
Bid
11.9
Ask
11.99
High 12.21 
Low 11.8 
Volume 2.66K 
Regular Hours (Closed)
Last
 11.64
-1.44 (-11.01%)
Day High 
13.595 
Prev. Close
13.08 
1-M High
16.8 
Volume 
1.18M 
Bid
11.9
Ask
11.99
Day Low
11.63 
Open
13.2 
1-M Low
7.21 
Market Cap 
282.01M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 13.53 
20-SMA 12.18 
50-SMA 14.63 
52-W High 65.8 
52-W Low 2.622 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-386.86/-7.01
Enterprise Value
309.63M
Balance Sheet
Book Value Per Share
-101.57
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OTLKOutlook Therapeutics0.66-0.92-58.23%0.58PE
Pre Market 0.6845 +0.0245 +3.71%
MREOMereo BioPharma Group plc0.5104+0.0937+22.49%-- 
Pre Market 0.554 +0.0436 +8.54%
SLSSELLAS Life Sciences Group4.35+0.58+15.38%-- 
Pre Market 4.81 +0.46 +10.57%
ASBPAspire Biopharma Holdings Inc.0.1369+0.005+3.79%-- 
Pre Market 0.1421 +0.0052 +3.80%
RXRXRecursion Pharmaceuticals4.2+0.11+2.69%-- 
Pre Market 4.28 +0.08 +1.90%
Industry overview quotes are at least 15 minutes delayed
Business Description
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.